OTCMKTS:GLDFF

Golden Leaf Competitors

$0.05
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.04
Now: $0.05
$0.05
50-Day Range
$0.04
MA: $0.05
$0.06
52-Week Range
$0.01
Now: $0.05
$0.09
Volume659,317 shs
Average Volume3.20 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Golden Leaf (OTCMKTS:GLDFF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying GLDFF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Golden Leaf, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Golden Leaf (OTCMKTS:GLDFF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.

Analyst Ratings

This is a breakdown of current ratings for Golden Leaf and Abacus Health Products, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Golden Leaf0000N/A
Abacus Health Products0000N/A

Valuation & Earnings

This table compares Golden Leaf and Abacus Health Products' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Golden LeafN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Profitability

This table compares Golden Leaf and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Golden LeafN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Golden Leaf (OTCMKTS:GLDFF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.

Analyst Ratings

This is a breakdown of current ratings for Golden Leaf and Acreage, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Golden Leaf0000N/A
Acreage01202.67

Acreage has a consensus price target of $8.4333, suggesting a potential upside of 204.45%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Golden Leaf.

Valuation & Earnings

This table compares Golden Leaf and Acreage's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Golden LeafN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Profitability

This table compares Golden Leaf and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Golden LeafN/AN/AN/A
AcreageN/AN/AN/A

Summary

Acreage beats Golden Leaf on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Golden Leaf (OTCMKTS:GLDFF) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for Applied Biosciences and Golden Leaf, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Golden Leaf0000N/A

Earnings & Valuation

This table compares Applied Biosciences and Golden Leaf's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Golden LeafN/AN/AN/AN/AN/A

Profitability

This table compares Applied Biosciences and Golden Leaf's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Golden LeafN/AN/AN/A

Ayr Strategies (OTCMKTS:AYRSF) and Golden Leaf (OTCMKTS:GLDFF) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for Ayr Strategies and Golden Leaf, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ayr Strategies01602.86
Golden Leaf0000N/A

Ayr Strategies currently has a consensus target price of $34.8571, suggesting a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts plainly believe Ayr Strategies is more favorable than Golden Leaf.

Earnings & Valuation

This table compares Ayr Strategies and Golden Leaf's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayr StrategiesN/AN/AN/AN/AN/A
Golden LeafN/AN/AN/AN/AN/A

Profitability

This table compares Ayr Strategies and Golden Leaf's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ayr StrategiesN/AN/AN/A
Golden LeafN/AN/AN/A

Summary

Ayr Strategies beats Golden Leaf on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Golden Leaf (OTCMKTS:GLDFF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Can B and Golden Leaf, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Golden Leaf0000N/A

Valuation & Earnings

This table compares Can B and Golden Leaf's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
Golden LeafN/AN/AN/AN/AN/A

Profitability

This table compares Can B and Golden Leaf's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
Golden LeafN/AN/AN/A

Cansortium (OTCMKTS:CNTMF) and Golden Leaf (OTCMKTS:GLDFF) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.

Analyst Ratings

This is a summary of recent ratings and price targets for Cansortium and Golden Leaf, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Golden Leaf0000N/A

Cansortium currently has a consensus target price of $1.20, suggesting a potential upside of 39.67%. Given Cansortium's higher possible upside, equities analysts clearly believe Cansortium is more favorable than Golden Leaf.

Valuation & Earnings

This table compares Cansortium and Golden Leaf's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
Golden LeafN/AN/AN/AN/AN/A

Profitability

This table compares Cansortium and Golden Leaf's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
Golden LeafN/AN/AN/A

Summary

Cansortium beats Golden Leaf on 2 of the 2 factors compared between the two stocks.


Golden Leaf Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84flat$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77flat$0.00N/A0.00
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.06flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
AYRSF
Ayr Strategies
1.4$21.26flat$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.50flat$0.00N/A0.00
Cansortium logo
CNTMF
Cansortium
1.1$0.86flat$0.00N/A0.00Decrease in Short Interest
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.19flat$0.00N/A0.00News Coverage
Gap Up
Choom logo
CHOOF
Choom
0.5$0.09flat$0.00N/A0.00Decrease in Short Interest
CPHRF
Cipher Pharmaceuticals
1.2$1.03flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.24flat$0.00N/A0.00News Coverage
Gap Up
Cosmos logo
COSM
Cosmos
0.5$5.68flat$0.00N/A0.00Increase in Short Interest
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.29flat$0.00N/A0.00Gap Up
Curaleaf logo
CURLF
Curaleaf
1.6$14.72flat$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00flat$0.00N/A0.00Decrease in Short Interest
Gap Up
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.14flat$0.00N/A0.00Increase in Short Interest
News Coverage
EVIO logo
EVIO
EVIO
0.6$0.00flat$0.00N/A0.00Increase in Short Interest
Gap Up
Flower One logo
FLOOF
Flower One
0.4$0.26flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01flat$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$29.17flat$0.00N/A0.00
GTEC logo
GGTTF
GTEC
0.6$0.63flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.91flat$0.00N/A0.00Gap Down
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.02flat$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.21flat$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.34flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.05flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05flat$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.44flat$0.00N/A0.00Decrease in Short Interest
News Coverage
KHTRF
Knight Therapeutics
1.2$4.21flat$0.00N/A0.00News Coverage
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05flat$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.39flat$0.00N/A0.00Increase in Short Interest
Gap Up
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.34flat$0.00N/A0.00Increase in Short Interest
News Coverage
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.26flat$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
1.1$0.08flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03flat$0.00N/A0.00Decrease in Short Interest
Gap Down
PHCEF
Pharmacielo
0.7$1.40flat$0.00N/A0.00News Coverage
Gap Up
Plus Products logo
PLPRF
Plus Products
1.1$0.54flat$0.00N/A0.00Decrease in Short Interest
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00flat$0.00N/A0.00
PCYN
Procyon
0.4$0.70flat$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01flat$0.00N/A0.00Decrease in Short Interest
News Coverage
SANP
Santo Mining
0.5$0.01flat$0.00N/A0.00News Coverage
Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.23flat$0.00N/A0.00High Trading Volume
Increase in Short Interest
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40flat$0.00N/A0.00
TerrAscend logo
TRSSF
TerrAscend
1.7$9.59flat$0.00N/A0.00Increase in Short Interest
The Flowr logo
FLWPF
The Flowr
1.5$0.25flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31flat$0.00N/A0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.